NEXT GENERATION RADIOLIGANDS

Welcome to the Brand page for “NEXT GENERATION RADIOLIGANDS”, which is offered here for Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “NEXT GENERATION RADIOLIGANDS” is believed to be currently owned by “Point Biopharma Inc.”